Table 9. Anti-HPV type 16/18 GMTs (EU/mL) in females 9 to 55 years of age.
| Assay (ELISA) Study cohorts | Anti-HPV type 16 | Anti-HPV type 18 | ||
|---|---|---|---|---|
| Geometric mean titre | 95% CI | Geometric mean titre | 95% CI | |
| 9 years | ||||
| Month 7 (122) | 31252.5 | 25463.6-38357.4 | 12628.5 | 10142.6-15723.8 |
| 10 to 14 years | ||||
| Month 7 (123) | 19882.0 | 18626.7-21221.9 | 8262.0 | 7725.0-8836.2 |
| Month 18 (123) | 3888.8 | 3605.0-4195.0 | 1539.0 | 1418.8-1670.3 |
| Month 36 (125) | 2675.5 | 2484.9-2880.8 | 972.0 | 896.5-1054.0 |
| Month 48 | 2374.9 | 2205.7-2557.0 | 864.8 | 796.9-938.4 |
| 15 to 25 years | ||||
| Month 7 (99) | 9341.5 | 8760.4-9961.1 | 4769.6 | 4491.2-5065.3 |
| Month 24 (124) | 1730.7 | 1462.3-2048.5 | 673.6 | 568.3-798.4 |
| Month 36 (126) | 1491.5 | 1260.9-1764.1 | 485.1 | 406.6-578.7 |
| Month 83 (127) | 383.4 | N/A | 251.0 | N/A |
| 26 to 45 years | ||||
| Month 7 (120) | 4029.2 | 3402.7-4771.0 | 1837.3 | 1602.1-2107.0 |
| Month 24 (127) | 733.0 | 603.7-890.1 | 280.8 | 235.3-335.1 |
| Month 36 (127) | 607.2 | 502.8-733.3 | 220.1 | 184.5-262.5 |
| 46 to 55 years | ||||
| Month 7 (120) | 2566.8 | 2181.2-3020.6 | 1313.0 | 1145.6-1504.9 |
| Month 24 | 472.9 | 396.8-563.6 | 185.7 | 156.3-220.6 |
| Month 36 (127) | 363.9 | 301.6-439.1 | 136.9 | 114.9-163.0 |
N/A, confidence intervals were not reported